Lucy Day An2 Therapeutics, Inc. (ANTX) insider trading activity

ANTX Quotes by TradingView

Lucy Day is Chief Financial Officer of AN2 Therapeutics, Inc.. Currently has a direct ownership of 75,363 shares of ANTX, which is worth approximately $85,913. The most recent transaction as insider was on Jan 06, 2026, when has been sold 5,512 shares (Common Stock) at a price of $1.01 per share, resulting in proceeds of $5,567. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.4K
4.81% 3M change
130.68% 12M change
Total Value Held $85,913

Lucy Day Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2026
SELL
Open market or private sale
$5,567 $1.01 p/Share
5,512 Reduced 6.82%
75,363 Common Stock
Jan 05 2026
SELL
Open market or private sale
$3,295 $1.0 p/Share
3,295 Reduced 3.91%
80,875 Common Stock
Feb 26 2025
BUY
Grant, award, or other acquisition
-
46,500 Added 37.0%
79,170 Common Stock
Jan 03 2025
SELL
Open market or private sale
$3,962 $1.34 p/Share
2,957 Reduced 8.3%
32,670 Common Stock
Mar 15 2024
BUY
Grant, award, or other acquisition
-
27,500 Added 47.31%
30,627 Common Stock
LD

Lucy Day

Chief Financial Officer
Menlo Park, CA

Track Institutional and Insider Activities on ANTX

Follow AN2 Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANTX shares.

Notify only if

Insider Trading

Get notified when an An2 Therapeutics, Inc. insider buys or sells ANTX shares.

Notify only if

News

Receive news related to AN2 Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANTX